Effect of Different Strategies for Titrating a High MAP on Microcirculation
Septic Shock, Hypertension
About this trial
This is an interventional treatment trial for Septic Shock focused on measuring septic shock; microcirculation; norepinephrine
Eligibility Criteria
Inclusion Criteria:
- Hypertensive patients with septic shock for less than 24 hours. Septic shock was defined by the 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
- Initial fluid resuscitation was performed to maintain the central venous pressure (CVP) for more than 8 mm Hg and central venous hemoglobin saturation for more than 70%.
- Patients were still requiring NE to maintain the MAP of 65 mm Hg.
Exclusion Criteria:
- had severe untreated or uncontrolled hypertension (systolic blood pressure more than 180 mm Hg or/and diastolic blood pressure more than 110 mm Hg);
- were younger than 18 years old or pregnant;
- were unable to acquire the usual level or resting level of blood pressure;
- refused to participate the trial.
Sites / Locations
- Nanjing Zhongda Hospital, Southeast University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Resp-FL
Resp-NE
Nonresp-NE
Patients received 500 ml crystalloid for fluid challenge within 20 minutes, then a PLR test was performed to predict fluid responsiveness. If the patient was fluid responsive, more 500 ml crystalloids were given until fluid nonresponsive. If the MAP still not achieved the target value, NE was increased to achieve the target one. The target MAP was maintain MAP within 10% of the reference value.
In Resp-NE group, norepinephrine was increased to enhance MAP within 10% of the reference value.
In Nonresp-NE group, norepinephrine was increased to enhance MAP within 10% of the reference value.